KZA 2.60% 39.5¢ kazia therapeutics limited

phase ii : are the results good enough to pass?

  1. 57 Posts.
    Is 20-30 % response rate for the ovarian cancer trials in Yale good enough to proceed to Phase III?

    Surely this would be be their major short medium term hurdle.

    Interested in your opinions on this.

    I hold NRT
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
0.01(2.60%)
Mkt cap $18.63M
Open High Low Value Volume
38.5¢ 39.5¢ 38.5¢ $1.541K 3.931K

Buyers (Bids)

No. Vol. Price($)
1 5000 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 3961 1
Last update - 11.40am 23/10/2018 (20 minute delay) ?
KZA (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.